Testing effectiveness (Phase 2)WithdrawnNCT04903054
What this trial is testing
Selective CD28 Blockade in Renal Transplant Recipients
Who this might be right for
Kidney TransplantationRenal Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID)